There was a time when a mink coat was the ultimate status item. It was seen as an investment piece passed down through generations. But grandma's mink coat may not be fought over anymore.
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant ...
"The dogs got a much, much bigger role than was originally intended," the 'Will & Grace' star said during an appearance on the 'Today' show ...
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant ...
MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in invariant natural killer T (iNKT) cell therapies, announced its financial results for the fourth quarter and ...
MiNK Therapeutics, Inc. to Announce Fourth Quarter and Year End 2024 Financial Results on March 18th
MiNK Therapeutics will release 2024 financial results on March 18, followed by a conference call at 8:30 a.m. ET. MiNK Therapeutics, Inc. has announced that it will release its financial results ...
25d
Detailed price information for Mink Therapeutics Inc (INKT-Q) from The Globe and Mail including charting and trades.
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback